EVP R&D, Chief Medical Officer
Wed, Apr 1, 2026
Apr 1
9,000 shares @ $35.51
Decreased holdings by -9.50%
24th largest trade (out of 152)
Trade made by an officer
10b5-1 scheduled trade
39% win rate · -4.2% median edge vs SPY (23 trades, 90-day)
Price 18% above 200-day moving average